Search Within

Renier J Brentjens

Formats
  1. Meeting Abstract (149)
  2. Journal Article (124)
  3. Review (5)
  4. Editorial (3)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Adult Leukemia (285)
  2. Center for Hematologic Malignancies (285)
  3. Department of Medicine (285)
  4. GSK Faculty (285)
  5. Hematologic Malignancies Research (285)
  6. Hematologic Malignancies, Division of (285)

More Groups

People
  1. Michel Sadelain (116)
  2. Isabelle Riviere (111)
  3. Jae Park (105)
  4. Xiuyan Wang (66)
  5. Terence Purdon (59)
  6. Elizabeth Halton (48)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (17)
  5. 2020 (25)
  6. 2019 (28)

More Years

Publications
  1. Blood (74)
  2. Journal of Clinical Oncology (26)
  3. Molecular Therapy (21)
  4. Cancer Research (10)
  5. Biology of Blood and Marrow Transplantation (8)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Hematology (79)
  2. Nature Publishing Group (52)
  3. American Association for Cancer Research (28)
  4. American Society of Clinical Oncology (27)
  5. Elsevier Inc. (25)
  6. Cell Press (6)

More Publishers

Results (285)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
    Journal Article

    Isshiki, Y.; Chen, X.; Teater, M.; Karagiannidis, I.; Nam, H.; Cai, W.; Meydan, C.; Xia, M.; Shen, H.; Gutierrez, J.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Manufacturing, characterization and anti-tumor activity of allogeneic CD19-CAR cytokine-induced killer (CIK) cells engineered with non-viral sleeping beauty transposon system and armored with IL-18
    Meeting Abstract

    Contreras-Ruiz, L.; Pace, B.; Kohnke, D. E.; Viruet, L.; Adams, M.; Krisko, J. F.; Leesnitzer, N.; Velie, M.; Tettamanti, S.; Pisani, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
    Meeting Abstract

    Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Engineering CAR-T cells to activate small-molecule drugs in situ
    Journal Article

    Gardner, T. J.; Lee, J. P.; Bourne, C. M.; Wijewarnasuriya, D.; Kinarivala, N.; Kurtz, K. G.; Corless, B. C.; Dacek, M. M.; Chang, A. Y.; Mo, G.; more...
    Nature Chemical Biology (2022)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: A preclinical model and initial clinical experience
    Journal Article

    Palomba, M. L.; Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Rivière, I.; Sadelain, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Biology of CAR-T cells
    Journal Article

    Berger, T. R.; Boardman, A.; Brentjens, R.; Maus, M. V.
    Cancer Drug Discovery and Development (2022)

    Fulltext@MSK | Save